Customer: Jiahui Asset

Industry: Financial Sector

Business: Logo Design, VI Design, Packaging Design

Address: Shenzhen, China

---

Jia Hui Asset was established in 2015, focusing on the cutting-edge biopharmaceutical research globally since its inception. The investment portfolio includes numerous pharmaceutical companies across various fields such as cancer, diabetes, cardiovascular diseases, and more. The investment regions span across Mainland China, Hong Kong, Taiwan, Canada, and others. Seizing the opportunities in China's healthcare reform, Jia Hui Asset has established industry subsidiaries in collaboration with the upstream and downstream of the industry to contribute to patients whose clinical needs are not yet met. The company also partnered with renowned venture capital firm H&Q Asia Pacific to launch the Jia Hui & Han Ding Biotech Fund, a joint management fund aimed at planning and industrializing more high-quality overseas pharmaceutical projects. Amidst rapid development, life on Earth faces various threats and challenges, yet there are still many disease pathologies to explore and research. We don't know what the world will look like tomorrow, but we persist in investing in life sciences to be prepared for the next clinical needs.